Shows Return News Today

In March 2023, Appropriate Use Criteria (AUC) for ER-targeted PET imaging was also published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI)

NCCN Guidelines® for clinicians and patients now recommend the use of FES PET for ER+ positive disease under certain circumstances during the systemic staging workup of patients with recurrent... | May 24, 2023

Live shows have returned to another Disneyland theater with the return of Mr. Smyth and Mr. Jones to Fantasylands Royal Theatre.

(1) GE Healthcare to scale Zionexas FDA-approved PET imaging agent, Cerianna (fluoroestradiol F-18), used as an adjunct to biopsy for the detection of estrogen receptor (ER) positive lesions to help inform treatment selection for patients with recurrent or metastatic breast cancer Aims to make Cerianna available to 75% of metastatic breast cancer patients in the U.S. by 2023 Acquisition demonstrates GE Healthcares commitment to its precision health vision and builds additional pipeline of onco...

GE Healthcare to scale Zionexa’s FDA-approved PET imaging agent, Cerianna (fluoroestradiol F-18), used as an adjunct to biopsy for the detection of estrogen receptor (ER) positive lesions to help inform treatment selection for patients with recurrent or metastatic breast cancer Aims to make Cerianna available to 75% of metastatic breast cancer patients in the U.S. by 2023 Acquisition demonstrates GE Healthcare’s commitment to its precision health vision and builds additional pipeline of onc...